- Home
- NSTS vs COCH Comparison
NSTS vs COCH Comparison
Compare NSTS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NSTS | COCH |
|---|---|---|
| Founded | 1921 | 1995 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Savings Institutions | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 59.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NSTS | COCH |
|---|---|---|
| Price | $11.70 | $0.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 6.8K | ★ 340.6K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $252,000.00 | N/A |
| Revenue This Year | N/A | $5.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.73 | $0.36 |
| 52 Week High | $13.06 | $1.91 |
Technical Indicators
Market Signals| Indicator | NSTS | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 47.23 | 45.70 |
| Support Level | $11.48 | $0.64 |
| Resistance Level | $12.38 | $0.73 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 49.32 | 19.18 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.